Bharat Biotech unveils new brand identity; Donates Rs 1 crore worth vaccines to celebrate 20 Years of ‘Leading Innovation’

2018-04-09 23:32:36

Over the last 20 years Bharat Biotech has a built a strong portfolio of more than 50 patents, 20+ commercially available safe, affordable and best in class vaccines and bio therapeutic products, accessible in over 100 countries.By Team ABLE Genome Valley based \"Clone-to-Clinic\" Indian biotechnology MNC, Bharat Biotech, unveiled its new corporate logo and its vision for the future. With its new l

Read more

Novo Nordisk get exclusive worldwide licence to EpiDestiny\'s sickle cell disease programme

2018-04-09 23:25:32

Novo Nordisk secures blood drug licence to boost anaemic biopharma businessBy Team ABLENovo Nordisk and EpiDestiny announced that Novo Nordisk has obtained an exclusive worldwide licence to EpiDestiny\'s sickle cell disease (SCD) programme, EPI01.EpiDestiny is eligible to receive more than 400 million US dollars in upfront, development and sales milestone payments and will get royalties on net sal

Read more

Biopharma caught in the crosshairs of US-China trade tussle

2018-04-09 23:24:04

Just a week after Johnson & Johnson chief Alex Gorsky and Novartis CEO Vasant Narasimhan expressed longing for stable and fair trade, biopharmaceuticals and medical devices have been dragged into the $100 billion trade war between the U.S. and China, the world’s two largest economies.Source: https://www.fiercepharma.com/pharma/despite-industry-wishes-biopharmaceuticals-caught-crosshairs-u-s-

Read more

BIO Announces Keynote and Returns to Boston June 4-7 to Celebrate 25 Years of History-Making Innovation

2018-04-09 23:08:46

The BIO International Convention will return to the Boston Convention & Exhibition Center, June 4-7, to celebrate 25 years of advocacy and innovation. By Team ABLEHosted by the Biotechnology Innovation Organization (BIO), the 2018 event is expected to attract more than 16,000 attendees and 1,800 exhibitors from 74 countries – all who will be welcomed in a special, keynote address by ABC’s

Read more

Shrikumar Suryanarayan of Sea6Energy takes over as ABLE President

2018-04-03 23:05:46

A new team of elected Executive Council, led by  Mr Shrikumar Suryanarayan, chairman of Sea6Energy, as President has taken charge at the Association of Biotechnology Led Enterprises (ABLE) on April 1, 2018.By Team ABLEABLE’s new executive committee  led by Shrikumar Suryanarayan  was , elected in November 2017. The team will hold office for the next three years, up to March 31, 20

Read more

“Jerky policies are a deterrent to biotech growth” Dr PM Murali

2018-03-30 07:27:42

DR PANCHAPAGESA MUTHUSWAMY MURALI takes a bow as the President of ABLE on March 31, 2018 after an illustrious three-year tenure as the CEO of India’s biotechnology industry organization, ABLE. This was his second three-year tenure at the helm of ABLE, starting in 2012. During the past years, ABLE has transformed from a small organization

Read more

Dr. Javed N Agrewala bags ‘JC Bose Fellowship’ Award

2018-03-29 09:16:58

Dr Javed of IIT Ropar has been awarded the ‘JC Bose Fellowship’ for his work on the development of novel vaccination strategies against tuberculosis.By Team ABLEDr. Javed N Agrewala, Professor, Centre for Biomedical Research, Indian Institute of Technology Ropar has been awarded the prestigious ‘JC Bose Fellowship’ for his work on the development of novel vaccination strategies against tub

Read more

Prof. K VijayRaghavan appointed as Principal Scientific Adviser to India

2018-03-29 09:15:35

Prof. K VijayRaghavan was appointed the Principal Scientific Adviser to the Government of India. He succeeds Dr. R. ChidambaramBy Team ABLEIt was announced on March 26, 2018, that ex-Secretary, Department of Biotechnology (DBT) and ex-Director of the National Centre for Biological Sciences (NCBS), Prof. K VijayRaghavan was appointed the Principal Scientific Adviser to the Government of India. He s

Read more

No GST on Research Services; Provisions under Section 13 (3)(a) regularized

2018-03-29 08:44:45

GST on R&D services involving R&D, prototyping, manufacturing arrangements, in-house development of molecules, testing processes, and other services, where reference material is supplied, now clarified.  By Team ABLEThe union government has in principle agreed to waive GST by regularizing the research services and export of services sections related to pharmaceuticals and biotechnolog

Read more

genedrive signs distribution agreement with ARKRAY Healthcare for RNA Assay

2018-03-29 02:12:19

Genedrive HCV ID Kit is a qualitative HCV RNA assayBy Team ABLEgenedrive plc, the near patient molecular diagnostics company, has signed a distribution agreement with ARKRAY Healthcare pvt Ltd, a wholly owned subsidiary of IVD company ARKRAY Inc. Japan, for its CE marked Genedrive HCV ID Kit and Genedrive platform in India.Under the agreement, genedrive will retain responsibility for product devel

Read more